Clinical Trials Directory

Trials / Completed

CompletedNCT00111228

The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT

Randomised, Controlled, Multi-centric, Clinical Study to Assess Whether Type 1 Diabetic Patients in Poor Glycemic Control Can Improve Using the Real-time Values of Guardian T Versus Conventional Self-Monitoring Blood Glucose

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
162 (actual)
Sponsor
Medtronic MiniMed, Inc. · Industry
Sex
All
Age
8 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The objective of the study is to determine whether patients with poor glycemic control can improve metabolic control using the real-time values of the Guardian® RT compared to conventional self-monitoring blood glucose finger-sticks.

Detailed description

Finger-stick based self-testing (SBGM), as well as diagnostic continuous glucose monitoring (CGMS®) allow diabetic patients to find a balance between the two hyper- and hypoglycemic extremes. Nevertheless, there are still patients who fail to achieve good control due to fear of hypoglycemia, or who underestimate post-prandial hyperglycemias. The Guardian® RT Telemetered Glucose Monitoring System is indicated for continuous or periodic monitoring of real-time interstitial blood glucose values and low/high blood glucose alarms (when pre-set levels are reached) in persons with diabetes mellitus. The glucose values calculated by the device will be used to trigger hypo- and hyperglycemia alerts and will be displayed every 5 minutes. The Guardian® RT stores up to 21 days of data. The overall primary objective of the study is to determine whether patients with poor glycemic control as evidenced by HbA1c \> 8.1% can achieve improved metabolic control using the real-time values of the Guardian® RT compared to conventional self-monitoring blood glucose finger-sticks (control group) after 12 weeks of continuous use.

Conditions

Interventions

TypeNameDescription
DEVICEGuardian RT
DEVICESMBG onlySMBG only

Timeline

Start date
2004-10-01
Primary completion
2005-05-01
Completion
2005-05-01
First posted
2005-05-19
Last updated
2019-04-01
Results posted
2019-04-01

Locations

8 sites across 7 countries: France, Germany, Israel, Italy, Slovenia, Sweden, United Kingdom

Source: ClinicalTrials.gov record NCT00111228. Inclusion in this directory is not an endorsement.